The Mount Sinai Health System is developing a care bundle for patients with venous thromboembolism (VTE) to improve care transitions from the hospital to outpatient settings. The bundle includes a smartphone app, care coordination tools, and improved documentation. The goal is to help patients adhere to treatment plans by eliminating gaps in care and ensuring patient needs are met. The initiative aims to serve as a model for improving transitions in other acute conditions. It received funding to develop and adopt evidence-based approaches over 24 months.
Presentation given to health-care management class discussing how military research impacts medical innovations eventually benefiting the civilian population
This document summarizes tissue engineering in dentistry. It discusses the key elements of tissue engineering including stem cells, morphogens, scaffolds and bioreactors. It outlines strategies such as conductive, inductive and cell transplantation approaches. Applications in dentistry are described for regenerating dentin-pulp complex, periodontium, bioengineered teeth, and other tissues like skin, bone and temporomandibular joints. The future of tissue engineering is promising for developing off-the-shelf bioproducts to replace lost oral and dental tissues.
3D Bioprinting Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...IMARC Group
According to the latest report by IMARC Group,finds that the global 3D bioprinting market reached a value of US$ 933.9 Million in 2021.3D bioprinting refers to the medical application of 3D printers for fabricating biological tissues and organs through the layering of living cells. It creates spatially-controlled patterns in 3D where viability and cell function are conserved within the printed construct. 3D bioprinting utilizes a layer-by-layer method to deposit materials like bio-inks. Bio-inks are obtained from living cells, biomaterials, and active biomolecules to create the 3D structure of tissues and organs.
The document summarizes discussions and presentations from the annual USC Body Computing Conference, which brings together leaders in medicine, technology, and healthcare to discuss advances in wireless medical solutions and mobile health. Key topics included using genomic data and mobile sensors to personalize cancer care and chronic disease management, monitoring health indicators remotely, and regulatory issues around mobile health apps and medical devices. Presenters demonstrated technologies for monitoring athletes and drivers' vital signs, and providing affordable healthcare access in developing nations.
This document summarizes a presentation on diagnostics and personalized medicine given on February 6, 2007. The presentation covers the overall size and structure of the in vitro diagnostics market, which is estimated at $41.6 billion globally with the US, Europe and Japan making up the majority. It also discusses key players in the market like Roche which has a 21% share, and trends in molecular diagnostics and novel protein markers. The presentation aims to challenge common assumptions and provide background on topics like nomenclature, marker validation and mining, and the role of personalized medicine.
This document discusses the importance of safety evaluation in the process of drug development. It notes that safety assessment is a fundamental component of the drug development lifecycle from preclinical to all clinical trial stages. The goal of safety evaluation is to characterize a drug's safety profile and establish its risks and benefits in order to obtain regulatory approval. Key aspects of safety evaluation discussed include conducting clinical trials according to good clinical practice guidelines, determining dose-response relationships and adverse effects, monitoring drugs post-marketing through pharmacovigilance, and using novel technologies to better understand drug safety.
The document summarizes an FDA presentation on the regulation of cellular, tissue, and gene therapies. It provides an overview of the FDA organization relevant to these therapies. It discusses premarket review pathways, recent guidance documents, current activities around stem cells, gene therapy, and tissue safety, and international engagement efforts towards regulatory harmonization.
This document discusses telemedicine and remote patient monitoring in the United States. It provides an overview of the growth and policies around telemedicine in the US. It specifically highlights Teladoc as the largest and first telemedicine company to have an IPO. Teladoc provides virtual visits via internet, phone or video chat and aims to provide care within 10 minutes. It has over 6,000 business customers and 11.5 million members. The document summarizes Teladoc's business model, revenue sources, and recent acquisition of HealthiestYou.
Presentation given to health-care management class discussing how military research impacts medical innovations eventually benefiting the civilian population
This document summarizes tissue engineering in dentistry. It discusses the key elements of tissue engineering including stem cells, morphogens, scaffolds and bioreactors. It outlines strategies such as conductive, inductive and cell transplantation approaches. Applications in dentistry are described for regenerating dentin-pulp complex, periodontium, bioengineered teeth, and other tissues like skin, bone and temporomandibular joints. The future of tissue engineering is promising for developing off-the-shelf bioproducts to replace lost oral and dental tissues.
3D Bioprinting Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and O...IMARC Group
According to the latest report by IMARC Group,finds that the global 3D bioprinting market reached a value of US$ 933.9 Million in 2021.3D bioprinting refers to the medical application of 3D printers for fabricating biological tissues and organs through the layering of living cells. It creates spatially-controlled patterns in 3D where viability and cell function are conserved within the printed construct. 3D bioprinting utilizes a layer-by-layer method to deposit materials like bio-inks. Bio-inks are obtained from living cells, biomaterials, and active biomolecules to create the 3D structure of tissues and organs.
The document summarizes discussions and presentations from the annual USC Body Computing Conference, which brings together leaders in medicine, technology, and healthcare to discuss advances in wireless medical solutions and mobile health. Key topics included using genomic data and mobile sensors to personalize cancer care and chronic disease management, monitoring health indicators remotely, and regulatory issues around mobile health apps and medical devices. Presenters demonstrated technologies for monitoring athletes and drivers' vital signs, and providing affordable healthcare access in developing nations.
This document summarizes a presentation on diagnostics and personalized medicine given on February 6, 2007. The presentation covers the overall size and structure of the in vitro diagnostics market, which is estimated at $41.6 billion globally with the US, Europe and Japan making up the majority. It also discusses key players in the market like Roche which has a 21% share, and trends in molecular diagnostics and novel protein markers. The presentation aims to challenge common assumptions and provide background on topics like nomenclature, marker validation and mining, and the role of personalized medicine.
This document discusses the importance of safety evaluation in the process of drug development. It notes that safety assessment is a fundamental component of the drug development lifecycle from preclinical to all clinical trial stages. The goal of safety evaluation is to characterize a drug's safety profile and establish its risks and benefits in order to obtain regulatory approval. Key aspects of safety evaluation discussed include conducting clinical trials according to good clinical practice guidelines, determining dose-response relationships and adverse effects, monitoring drugs post-marketing through pharmacovigilance, and using novel technologies to better understand drug safety.
The document summarizes an FDA presentation on the regulation of cellular, tissue, and gene therapies. It provides an overview of the FDA organization relevant to these therapies. It discusses premarket review pathways, recent guidance documents, current activities around stem cells, gene therapy, and tissue safety, and international engagement efforts towards regulatory harmonization.
This document discusses telemedicine and remote patient monitoring in the United States. It provides an overview of the growth and policies around telemedicine in the US. It specifically highlights Teladoc as the largest and first telemedicine company to have an IPO. Teladoc provides virtual visits via internet, phone or video chat and aims to provide care within 10 minutes. It has over 6,000 business customers and 11.5 million members. The document summarizes Teladoc's business model, revenue sources, and recent acquisition of HealthiestYou.
This document reviews the toxicity profile of methotrexate (MTX) in patients being treated for rheumatoid arthritis. It discusses several common toxicities associated with MTX including gastrointestinal issues, skin/mucous membrane effects, hematological effects, central nervous system effects, respiratory effects, hepatic toxicity, increased risk of infections, and kidney/reproductive system effects. The review provides details on the frequency and severity of each toxicity based on data from clinical studies. It concludes that while MTX remains a standard treatment for rheumatoid arthritis, physicians must be aware of its potential risks and monitor patients accordingly.
Company x anti infective orthopedic implant drug device preliminary final rep...Brand Acumen
The document provides a market research report on the potential market for an anti-infective orthopaedic implant drug-device combination being developed by Company X. It summarizes interviews with 27 key opinion leaders in orthopaedics. The KOLs believe the market potential is high, particularly for procedures with high infection risks like open fractures and spinal/joint surgeries. However, efficacy must be proven through clinical trials demonstrating a significant reduction in infections. Regulatory approval and reimbursement will also depend on cost-effectiveness analyses. Concerns include antibiotic resistance, allergic reactions, and foreign body reactions.
You're correct. FaceNet, developed by Google, achieved 99.63% accuracy on the Labeled Faces in the Wild (LFW) dataset, significantly higher than both DeepFace (97.35%) and the original baseline (95%). Deep learning models for face recognition have improved dramatically in recent years.
2014 Overview of significant trends in the life sciences (Biotechnology, Pharmaceutical, Device and Diagnostics) industry with Big Data in the Life Sciences featured articles.
Company x pump for convection enhanced delivery (ced) market entry validatio...Brand Acumen
Existing drug delivery approaches for brain tumors have limitations in spatial penetration and distribution. Convection enhanced delivery (CED) has advantages over other methods, but identifying the right therapeutic molecules is still a challenge. Key opinion leaders see opportunities for CED to deliver drugs, nanoparticles, antibodies, and viruses to brain tumors. However, more data is needed comparing drug concentrations from CED versus intravenous or oral administration. Additionally, catheter placement accuracy and standardizing training could help address some problems with CED approaches.
Recent advances and challenges of digital mental healthcareYoon Sup Choi
This document discusses research analyzing the relationship between mobile phone location sensor data and measures of depressive symptom severity. The research replicated a previous study finding significant correlations between several GPS-derived features (location variance, entropy, circadian movement) and scores on the PHQ-9 depression scale. These relationships were stronger when analyzing weekend versus weekday GPS data. GPS features predicted PHQ-9 scores up to 10 weeks later, suggesting they may serve as early warning signals of depression. The findings provide further evidence that passively collected GPS data from smartphones can reliably predict depressive symptom severity.
14 technologies that will shape the future of cancer careMpower Medical Inc
The document discusses 14 technologies that will shape the future of cancer care, including fluid biopsy, which extracts cancer cells from blood samples; real-time cancer diagnostics using devices like the "iKnife" surgical tool; and artificial intelligence to design personalized therapy based on a patient's genetic profile and other factors. It also covers precision surgery using robotic tools, embedded sensors to remotely monitor patients, and social networks to help patients cope with treatment side effects. These technologies aim to revolutionize cancer prevention, diagnosis, treatment, and long-term patient care and support.
(1) The system segments histopathology images into epithelial and stromal regions and identifies nuclei.
(2) It constructs a rich set of quantitative features describing the relationships between different image objects.
(3) Using the features, a predictive model is built from images of patients with known 5-year survival outcomes. This model can then predict survival probabilities for new unlabeled images.
From “Big Data” to Digital Medicine--PYA Explores Innovations in HealthcarePYA, P.C.
With reform in healthcare and advancements in technology, the future of medicine is in a state of flux. What it all means can be heard in discussions from coast-to-coast, in the halls of hospitals, at conferences, and in board rooms.
Among the thought leaders who have broached this timely subject is PYA Principal Kent Bottles, MD, who is also PYA Analytics’ Chief Medical Officer. He recently spoke at The North American Menopause Society Annual Meeting on the topic: “The Perils and Prospects of Practicing Medicine in a Digital Era.”
Smartphone Applications and its Role in Foot and Ankle Surgeryijtsrd
Introduction The coronavirus disease 19 COVID 19 pandemic has exposed inherent weaknesses in global healthcare systems. Conversely, it has encouraged innovation, research and collaboration. Digital technology has the ability to tackle these difficulties via the use of applications. However, the reliability and validity of unregulated medical applications must be questioned. The aim of this study was to review surgical foot and ankle themed applications and specifically assess the level of involvement from medical professionals in the design and content. Methods The App Store iOS , Google Play Android and the BlackBerry App World Blackberry were searched for foot and ankle themed applications. The following search terms were used bunions, ankle sprains, diabetic foot, foot and ankle deformities, pre op templating, Patho anatomy, post operative rehab, gait, measurement of clinical angles of foot and ankle. Data were collected on target audience, patients, healthcare workers, number of applications, applications with customer satisfaction reviews, applications with medical professional involvement and applications available within the UK application stores. Results 35 individual foot and ankle themed applications were identified. 30 applications had customer satisfaction ratings, 11 applications were predominantly health worker centric and 3 were patient centered. 23 applications had medical professional involvement in their development or content. Conclusion The benefits of applications are offset by the lack of Foot and ankle specification. There is relatively little medical professional involvement in their design. Increased regulation is required to improve accountability of application content. Dr. Prashanth Nagaraj | Mr Davinder Singh Paul Baghla | Miss Samantha Z Tross "Smartphone Applications and its Role in Foot and Ankle Surgery" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd43642.pdf Paper URL: https://www.ijtsrd.commedicine/surgery/43642/smartphone-applications-and-its-role-in-foot-and-ankle-surgery/dr-prashanth-nagaraj
There are only around 500 geneticists and 2,400 genetic counselors in the U.S. to help integrate genomic medicine into patient care. DNA Direct aims to address this shortage and other barriers through technology solutions that provide education, decision support, and expert guidance to patients, providers, payors, and medical centers. Their programs have shown success in improving patient compliance with genetic screening and understanding of test results.
This document outlines a communication plan to gain government support and regulation for CRISPR gene editing technology research. The plan aims to position Editas Medicine as supporting people by expanding partnerships under government guidance. Key strategies include passing legislation for FDA oversight, increasing public support through media, and influencing researchers. Target audiences are government officials, the general public, and industry leaders. Messages focus on CRISPR's medical potential and benefits of stable, ethical research through federal backing aligned with global standards. The goal is to increase the likelihood of continued, responsible CRISPR research delivering life-changing treatments to the public.
This document discusses Kaiser Permanente's implementation and use of electronic health records (EHRs). It provides background on Kaiser Permanente, describing how it originated and its current operations. It then discusses Kaiser Permanente's early adoption of EHR technology, the selection of Epic Systems as its EHR vendor, and some of the EHR systems implemented like MyChart. The implementation of its EHR system called HealthConnect is described, including some initial problems. It concludes by noting that Kaiser Permanente has now completed rolling out HealthConnect.
디지털 헬스케어를 어떻게 구현할 것인가: 국내 스타트업 업계를 중심으로Yoon Sup Choi
You're correct. FaceNet, developed by Google, achieved state-of-the-art performance on the Labeled Faces in the Wild (LFW) dataset, with a reported accuracy of 99.63%. This surpasses both the 95% accuracy of earlier systems as well as DeepFace from Facebook, which achieved 97.35% accuracy on LFW. FaceNet demonstrates the rapid progress being made in deep learning for face recognition tasks.
This presentation contains an introduction to emerging healthcare Technologies. These emerging technologies include Data Analytics, AI, Blockchain, Telehealth, virtual reality, cloud computing, and IOT. The concept of Nanorobots as future medicine is also included in this presentation.
- The traditional business model of personal genomics companies sees individuals pay to sequence their genomes and receive analysis results, while the companies keep the genomic data and sell it to pharmaceutical companies. However, this model has limitations in addressing high sequencing costs for individuals, lack of individual control over their data, and lack of incentives.
- The proposed Nebula model uses blockchain technology to connect individuals directly with data buyers, eliminating personal genomics companies as middlemen. This is intended to reduce sequencing costs for individuals, give them control over their genomic data and how it is used, and provide incentives.
- The model aims to satisfy both individuals, by addressing the above issues, and data buyers' needs around data availability, acquisition, and
Mike Jackson, Chairman of Shaping Tomorrow, presented on the future of healthcare. Key points include:
1) Healthcare systems have lagged 10 years in translating clinical research into practice, neglecting major health issues. Continuous scanning is needed to enable preventative and predictive care.
2) Future healthcare will be predictive, preventative, precise, participatory and personalized through technologies like genomics, digital implants, and mobile health monitoring.
3) By 2025, patients will be at the center of their own care, aided by new technologies, while universal genetics and regenerative medicine become standard. Healthcare will increasingly shift to the home instead of institutions.
Heath care projects need high level of investment, diverse set of stakeholders, and comply with rigorous federal and state regulations, and standards. In addition, project outcomes have direct impact on safety and well-being of patients. This speech focuses on challenges and opportunities in implementing Health care IT projects. Also discusses strategies to adopt agile methodologies in health care industry. Finally, highlights critical success factors in implementing Healthcare Projects successfully.
Learning Outcomes:
Understand characteristics of Healthcare projects
Learn challenges and opportunities in implementing Healthcare projects
Learn agile adoption strategies in Health IT
Learn and apply Critical Success Factors to improve project success
Trends April 2015 book review scope issueLinda Gross
The U.S. Centers for Medicare & Medicaid Services announced an oncology payment model intended to reward quality care and reduce costs. The model aims to set bounds on oncology costs by rewarding oncologists who meet quality benchmarks for Medicare beneficiaries undergoing chemotherapy. It is a five-year pilot program that combines quality benchmarks within six-month episodes of care with fee-for-service reimbursement. The program requires practices to provide 24/7 patient access and use of electronic health records to better manage complex cancer care.
This document reviews the toxicity profile of methotrexate (MTX) in patients being treated for rheumatoid arthritis. It discusses several common toxicities associated with MTX including gastrointestinal issues, skin/mucous membrane effects, hematological effects, central nervous system effects, respiratory effects, hepatic toxicity, increased risk of infections, and kidney/reproductive system effects. The review provides details on the frequency and severity of each toxicity based on data from clinical studies. It concludes that while MTX remains a standard treatment for rheumatoid arthritis, physicians must be aware of its potential risks and monitor patients accordingly.
Company x anti infective orthopedic implant drug device preliminary final rep...Brand Acumen
The document provides a market research report on the potential market for an anti-infective orthopaedic implant drug-device combination being developed by Company X. It summarizes interviews with 27 key opinion leaders in orthopaedics. The KOLs believe the market potential is high, particularly for procedures with high infection risks like open fractures and spinal/joint surgeries. However, efficacy must be proven through clinical trials demonstrating a significant reduction in infections. Regulatory approval and reimbursement will also depend on cost-effectiveness analyses. Concerns include antibiotic resistance, allergic reactions, and foreign body reactions.
You're correct. FaceNet, developed by Google, achieved 99.63% accuracy on the Labeled Faces in the Wild (LFW) dataset, significantly higher than both DeepFace (97.35%) and the original baseline (95%). Deep learning models for face recognition have improved dramatically in recent years.
2014 Overview of significant trends in the life sciences (Biotechnology, Pharmaceutical, Device and Diagnostics) industry with Big Data in the Life Sciences featured articles.
Company x pump for convection enhanced delivery (ced) market entry validatio...Brand Acumen
Existing drug delivery approaches for brain tumors have limitations in spatial penetration and distribution. Convection enhanced delivery (CED) has advantages over other methods, but identifying the right therapeutic molecules is still a challenge. Key opinion leaders see opportunities for CED to deliver drugs, nanoparticles, antibodies, and viruses to brain tumors. However, more data is needed comparing drug concentrations from CED versus intravenous or oral administration. Additionally, catheter placement accuracy and standardizing training could help address some problems with CED approaches.
Recent advances and challenges of digital mental healthcareYoon Sup Choi
This document discusses research analyzing the relationship between mobile phone location sensor data and measures of depressive symptom severity. The research replicated a previous study finding significant correlations between several GPS-derived features (location variance, entropy, circadian movement) and scores on the PHQ-9 depression scale. These relationships were stronger when analyzing weekend versus weekday GPS data. GPS features predicted PHQ-9 scores up to 10 weeks later, suggesting they may serve as early warning signals of depression. The findings provide further evidence that passively collected GPS data from smartphones can reliably predict depressive symptom severity.
14 technologies that will shape the future of cancer careMpower Medical Inc
The document discusses 14 technologies that will shape the future of cancer care, including fluid biopsy, which extracts cancer cells from blood samples; real-time cancer diagnostics using devices like the "iKnife" surgical tool; and artificial intelligence to design personalized therapy based on a patient's genetic profile and other factors. It also covers precision surgery using robotic tools, embedded sensors to remotely monitor patients, and social networks to help patients cope with treatment side effects. These technologies aim to revolutionize cancer prevention, diagnosis, treatment, and long-term patient care and support.
(1) The system segments histopathology images into epithelial and stromal regions and identifies nuclei.
(2) It constructs a rich set of quantitative features describing the relationships between different image objects.
(3) Using the features, a predictive model is built from images of patients with known 5-year survival outcomes. This model can then predict survival probabilities for new unlabeled images.
From “Big Data” to Digital Medicine--PYA Explores Innovations in HealthcarePYA, P.C.
With reform in healthcare and advancements in technology, the future of medicine is in a state of flux. What it all means can be heard in discussions from coast-to-coast, in the halls of hospitals, at conferences, and in board rooms.
Among the thought leaders who have broached this timely subject is PYA Principal Kent Bottles, MD, who is also PYA Analytics’ Chief Medical Officer. He recently spoke at The North American Menopause Society Annual Meeting on the topic: “The Perils and Prospects of Practicing Medicine in a Digital Era.”
Smartphone Applications and its Role in Foot and Ankle Surgeryijtsrd
Introduction The coronavirus disease 19 COVID 19 pandemic has exposed inherent weaknesses in global healthcare systems. Conversely, it has encouraged innovation, research and collaboration. Digital technology has the ability to tackle these difficulties via the use of applications. However, the reliability and validity of unregulated medical applications must be questioned. The aim of this study was to review surgical foot and ankle themed applications and specifically assess the level of involvement from medical professionals in the design and content. Methods The App Store iOS , Google Play Android and the BlackBerry App World Blackberry were searched for foot and ankle themed applications. The following search terms were used bunions, ankle sprains, diabetic foot, foot and ankle deformities, pre op templating, Patho anatomy, post operative rehab, gait, measurement of clinical angles of foot and ankle. Data were collected on target audience, patients, healthcare workers, number of applications, applications with customer satisfaction reviews, applications with medical professional involvement and applications available within the UK application stores. Results 35 individual foot and ankle themed applications were identified. 30 applications had customer satisfaction ratings, 11 applications were predominantly health worker centric and 3 were patient centered. 23 applications had medical professional involvement in their development or content. Conclusion The benefits of applications are offset by the lack of Foot and ankle specification. There is relatively little medical professional involvement in their design. Increased regulation is required to improve accountability of application content. Dr. Prashanth Nagaraj | Mr Davinder Singh Paul Baghla | Miss Samantha Z Tross "Smartphone Applications and its Role in Foot and Ankle Surgery" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd43642.pdf Paper URL: https://www.ijtsrd.commedicine/surgery/43642/smartphone-applications-and-its-role-in-foot-and-ankle-surgery/dr-prashanth-nagaraj
There are only around 500 geneticists and 2,400 genetic counselors in the U.S. to help integrate genomic medicine into patient care. DNA Direct aims to address this shortage and other barriers through technology solutions that provide education, decision support, and expert guidance to patients, providers, payors, and medical centers. Their programs have shown success in improving patient compliance with genetic screening and understanding of test results.
This document outlines a communication plan to gain government support and regulation for CRISPR gene editing technology research. The plan aims to position Editas Medicine as supporting people by expanding partnerships under government guidance. Key strategies include passing legislation for FDA oversight, increasing public support through media, and influencing researchers. Target audiences are government officials, the general public, and industry leaders. Messages focus on CRISPR's medical potential and benefits of stable, ethical research through federal backing aligned with global standards. The goal is to increase the likelihood of continued, responsible CRISPR research delivering life-changing treatments to the public.
This document discusses Kaiser Permanente's implementation and use of electronic health records (EHRs). It provides background on Kaiser Permanente, describing how it originated and its current operations. It then discusses Kaiser Permanente's early adoption of EHR technology, the selection of Epic Systems as its EHR vendor, and some of the EHR systems implemented like MyChart. The implementation of its EHR system called HealthConnect is described, including some initial problems. It concludes by noting that Kaiser Permanente has now completed rolling out HealthConnect.
디지털 헬스케어를 어떻게 구현할 것인가: 국내 스타트업 업계를 중심으로Yoon Sup Choi
You're correct. FaceNet, developed by Google, achieved state-of-the-art performance on the Labeled Faces in the Wild (LFW) dataset, with a reported accuracy of 99.63%. This surpasses both the 95% accuracy of earlier systems as well as DeepFace from Facebook, which achieved 97.35% accuracy on LFW. FaceNet demonstrates the rapid progress being made in deep learning for face recognition tasks.
This presentation contains an introduction to emerging healthcare Technologies. These emerging technologies include Data Analytics, AI, Blockchain, Telehealth, virtual reality, cloud computing, and IOT. The concept of Nanorobots as future medicine is also included in this presentation.
- The traditional business model of personal genomics companies sees individuals pay to sequence their genomes and receive analysis results, while the companies keep the genomic data and sell it to pharmaceutical companies. However, this model has limitations in addressing high sequencing costs for individuals, lack of individual control over their data, and lack of incentives.
- The proposed Nebula model uses blockchain technology to connect individuals directly with data buyers, eliminating personal genomics companies as middlemen. This is intended to reduce sequencing costs for individuals, give them control over their genomic data and how it is used, and provide incentives.
- The model aims to satisfy both individuals, by addressing the above issues, and data buyers' needs around data availability, acquisition, and
Mike Jackson, Chairman of Shaping Tomorrow, presented on the future of healthcare. Key points include:
1) Healthcare systems have lagged 10 years in translating clinical research into practice, neglecting major health issues. Continuous scanning is needed to enable preventative and predictive care.
2) Future healthcare will be predictive, preventative, precise, participatory and personalized through technologies like genomics, digital implants, and mobile health monitoring.
3) By 2025, patients will be at the center of their own care, aided by new technologies, while universal genetics and regenerative medicine become standard. Healthcare will increasingly shift to the home instead of institutions.
Heath care projects need high level of investment, diverse set of stakeholders, and comply with rigorous federal and state regulations, and standards. In addition, project outcomes have direct impact on safety and well-being of patients. This speech focuses on challenges and opportunities in implementing Health care IT projects. Also discusses strategies to adopt agile methodologies in health care industry. Finally, highlights critical success factors in implementing Healthcare Projects successfully.
Learning Outcomes:
Understand characteristics of Healthcare projects
Learn challenges and opportunities in implementing Healthcare projects
Learn agile adoption strategies in Health IT
Learn and apply Critical Success Factors to improve project success
Trends April 2015 book review scope issueLinda Gross
The U.S. Centers for Medicare & Medicaid Services announced an oncology payment model intended to reward quality care and reduce costs. The model aims to set bounds on oncology costs by rewarding oncologists who meet quality benchmarks for Medicare beneficiaries undergoing chemotherapy. It is a five-year pilot program that combines quality benchmarks within six-month episodes of care with fee-for-service reimbursement. The program requires practices to provide 24/7 patient access and use of electronic health records to better manage complex cancer care.
Disruptors in the Medical Imaging IndustryBill Kelly
An overview of the Disruptors in the Medical Imaging Market. This free webinar will also give you more insight on the various factors that influence the market. We touch on results from a survey of a survey of 147 radiologists highlight the importance of reimbursement changes –both “appropriateness” measures and value-based medicine – as the most significant factors that will impact the imaging market.
The document discusses Strand Genomics Inc., which offers genomic analysis and clinical interpretation software and services. It focuses on personalized medicine by using its StrandOmics platform to analyze genomic data and determine disease risks for individuals. StrandOmics aims to make genomic testing routine in medical care to help clinicians make more informed decisions. Strand has grown to over 200 scientists and serves over 2,000 labs and 100,000 patients. Its partnership with Health Care Global Enterprises successfully piloted cancer risk assessment and molecular diagnosis for over 50 patients in India.
This document provides a summary of news stories from the August 8, 2013 issue of Medical Device Daily. The stories include:
1) Medtronic implanted its new deep brain stimulation plus sensing system that enables sensing and recording of select brain activity while providing targeted therapy, which could change the treatment of neurological disorders.
2) A study in the UK found that showing cardiologists a quantification of coronary lesion severity changed treatment plans for 26% of patients, highlighting the diagnostic value of fractional flow reserve.
3) FDA finalized guidance on clinical trial site monitoring that provides greater details on responsibilities when a sponsor hands off monitoring work to a contract research organization.
IRJET - Health Care Abbreviation System for Organ DonationIRJET Journal
This document discusses organ donation and transplantation. It proposes a new system called Confident Match to improve organ matching between donors and recipients. The system would be trained on electronic health record data to predict transplant success based on donor and recipient traits. It aims to provide more personalized predictions for recipient-donor pairs by optimally dividing features into clusters and building different predictive models for each cluster. Experimental results on heart transplant data showed Confident Match could predict success for more patients than competing methods, with 95% accuracy for over 5,000 patients.
This is a comprehensive report on medical devices interoperability in India
This report covers global developments in interoperability of medical devices
Real-World Evidence: The Future of Data Generation and UsageApril Bright
As data is captured through electronic health records, registries and unique device identifiers, the generation of evidence based on this data is expected to play a crucial role in informing orthopedic manufacturers’ decisions before and after regulatory approval. While regulators, payors, hospitals and manufacturers support this shift, they acknowledge that gaps remain in its optimal execution. Priority considerations include how to generate evidence to expedite regulatory market decisions, device indication expansion, postmarket studies, postmarket surveillance and reimbursement decisions. The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), is leading the conversation with various stakeholders, including FDA and orthopedic device companies to support the sustainable generation of Real-World Evidence (RWE) using Real-World Data (RWD).
The document summarizes the work experience and responsibilities of an analyst in the medical device industry. Key responsibilities included conducting primary and secondary research through interviews and data collection to analyze market dynamics, trends, and growth forecasts for medical devices. Reports were written on various medical device markets such as arthroscopy devices, orthopedic joint replacement, ultrasound devices, MRI, x-rays, and the dental industry. The analyst leveraged relationships with industry executives to provide insights and analyzed factors driving growth in various medical device markets.
Healthy Savings. Medical Technology and the Economic Burden of DiseaseRevital (Tali) Hirsch
As America ages and sedentary lifestyles and unhealthy diets become more common, experts agree the nation is suffering a sharp rise in the prevalence of chronic disease. As the 21st century unfolds, technology – in the form of advanced diagnostic and therapeutic devices -- can meet the need for early detection and more effective management of illness. Some researchers, however, have questioned whether the overall benefit of technical advances outweighs the costs -- a question this report definitively answers.
Accordingly, researchers at the Milken Institute undertook a comprehensive, quantitative documentation of medical technology's impact on the economic burden of disease. The study also projects how future innovation in this sector would affect the health care system and the larger economy -- a positive benefit of more than $23 billion a year for the United States.
The study takes a systematic approach to documenting the full costs and broader economic benefits of health care investments by examining innovations pertaining to four prevalent causes of disability and death: heart disease, diabetes, colorectal cancer, and musculoskeletal disease. The report considers therapeutics and diagnostic devices that are widely used and have substantially affected the lives of patients as well as the overall U.S. economy. Among the 10 devices or device-based procedures studied are pacemakers, insulin infusion pumps, colonoscopies, and joint replacement surgery.
The data demonstrate that the use of medical technology brings considerable economic benefits. These are seen in both aggregate savings in treatment expenditures and prevention as well as the reduction of "indirect impact" through larger contributions to the economy.
Biomaterials for medical implantation research strategies - PubricaPubrica
Biomaterials and medical instruments are widely researched and incorporated, which greatly increase the quality of human life, thanks to the rapid advancement of biomedical science and practice
Continue Reading: https://bit.ly/2UOpyqw
For our services: https://pubrica.com/sevices/research-services/
Why Pubrica:
When you order our services, We promise you the following – Plagiarism free | always on Time | 24*7 customer support | Written to international Standard | Unlimited Revisions support | Medical writing Expert | Publication Support | Biostatistical experts | High-quality Subject Matter Experts.
Contact us:
Web: https://pubrica.com/
Blog: https://pubrica.com/academy/
Email: sales@pubrica.com
WhatsApp : +91 9884350006
United Kingdom: +44-1618186353
This document describes a multi-disciplinary project called Designing Out Medical Error (DOME) that aimed to improve patient safety by applying human factors and design principles. The project mapped out processes in surgical ward bedspaces and identified nearly 200 potential failure modes. Solutions addressed issues like equipment design, reminders, monitoring, feedback and standardization. Some solutions, like the CareCentre workstation, were developed into prototypes and tested clinically. The project demonstrated the value of a multi-disciplinary approach and applying human factors principles throughout the design cycle to develop safer healthcare products.
In this work, we describe the field research, design, and comparative deployment of a multimodal medical imaging user interface for breast screening. The main contributions described here are threefold: 1) The design of an advanced visual interface for multimodal diagnosis of breast cancer (BreastScreening); 2) Insights from the field comparison of Single-Modality vs Multi-Modality screening of breast cancer diagnosis with 31 clinicians and 566 images; and 3) The visualization of the two main types of breast lesions in the following image modalities: (i) MammoGraphy (MG) in both Craniocaudal (CC) and Mediolateral oblique (MLO) views; (ii) UltraSound (US); and (iii) Magnetic Resonance Imaging (MRI).
This document discusses using data mining techniques like association rule mining and improved apriori algorithm with fuzzy logic to develop an expert system that can predict the risk of osteoporosis based on a patient's clinical data and history. It aims to help doctors make more informed decisions early on to prevent osteoporosis. The system would find relationships between various risk factors and diagnose osteoporosis severity to identify at-risk patients before costly tests. Literature on using different algorithms like decision trees and neural networks for medical diagnosis and predicting osteoporosis risk is also reviewed.
Guideline for the Prevention of Surgical Site Infection, 2017RubenMariscal3
This guideline provides evidence-based recommendations for preventing surgical site infections (SSIs). Key recommendations include administering preoperative antimicrobial prophylaxis timed with surgery, maintaining normothermia and glycemic control in patients, and avoiding additional antimicrobial doses after surgery. The guideline is intended to improve patient safety by reducing preventable SSIs and incorporating strategies into surgical quality improvement programs. It is based on a systematic review of the literature evaluating various prevention practices and aims to advance the field by assessing areas deemed important by clinical experts.
This document discusses strategies for standardizing handoff processes throughout healthcare organizations. It explains that standardizing handoffs is challenging but important for patient safety, as ineffective handoffs can lead to medical errors and other issues. The document outlines some key steps for organizations to take, such as developing and implementing a standardized process, obtaining leadership and staff buy-in, and addressing hierarchical relationships among staff that can hinder communication. Standardizing handoffs requires significant cultural change across an entire organization.
A SPECIAL S U P P L E H E N T TO THE HHTIHGS CENTEH REPOUT.docxbartholomeocoombs
This document provides an overview and summary of a report from The Hastings Center on promoting patient safety through policy deliberation. Some key points:
- The report was prompted by the 1999 IOM report "To Err is Human" which estimated medical errors result in up to 98,000 deaths per year in the US.
- The IOM report recommended establishing a national patient safety center and mandatory reporting of serious medical errors to track safety performance. This sparked significant policy debate and reform efforts.
- This Hastings Center report discusses the ethical values and principles underlying patient safety efforts such as beneficence, non-maleficence, and fiduciary responsibility to patients. It also addresses tensions between individual accountability and systemic
The document discusses the current state and expected growth trends of the in vitro diagnostics (IVD) market. It notes that the global IVD market was estimated at $54.2 billion in 2013 and is expected to grow 4% annually to $64.3 billion by 2018. Technological advances in areas like genomics, bioinformatics, and miniaturization have transformed diagnostic laboratory technology in recent years. Personalized medicine, infectious disease testing, and other applications are driving growth in the IVD market. However, economic instability, rising healthcare costs, and reimbursement changes pose challenges for the industry.
Make DNA data actionable - Festival of Genomics London 2018Omar Fogliadini
The document discusses the emerging field of genomic medicine and direct-to-consumer genetic testing. It notes that the cost of genome sequencing has dropped dramatically in recent years, enabling more people to access their genetic data. However, most doctors currently lack training in genomics and the implications of genetic testing. The development of genomic medicine will require greater integration of genetics into healthcare systems and medical education. The document also examines some of the challenges in ensuring patients and doctors can properly understand and act on genetic results.
Similar to Trends April 2016 bone cement VTE and hips (20)
Make DNA data actionable - Festival of Genomics London 2018
Trends April 2016 bone cement VTE and hips
1. 5200 Butler Pike, Plymouth Meeting, PA 19462-1298, USA Tel +1 (610) 825-6000 Fax +1 (610) 834-1275 Web www.ecri.org E-mail info@ecri.org
IN THIS ISSUE
Health Technology
TRENDS
April 2016 | Vol. 28, No. 4
Bone cement. Based on the
evidence, antibiotic bone cement
use may be more appropriate in
patents at high risk of developing
an infection after hip and knee
joint replacement surgery,
compared with non-antibiotic bone
cement use. More appropriate use
could result in opportunities to
reduce spending. p1
Bundled payments for VTE.
Mount Sinai Health System is
striving to improve transitions
of care for patients with
venous thromboembolism
by developing a care bundle
including a smartphone
app, care coordination, and
improved documentation and
communication tools. Health
Technology Trends spoke with
program developers to discuss
how the project evolved and
where it might be headed. p4
Metal-on-metal hips. The U.S.
Food and Drug Administration
issued its final rule on metal-on-
metal hip replacement devices.
Manufacturers have until Mid-
May to obtain premarket approval
for devices—some of which may
be sitting on hospital inventory
shelves. p6
IN UPCOMING ISSUES
Will your EHRs be held for
ransom?
Limiting Antibiotic Bone Cement
in Arthroplasty to High-risk
Patients Yields Savings
As arthroplasty rates rise for hips and knees
with the aging of the baby boom generation
and the obesity epidemic, many hospitals are
looking at every element contributing to the
cost of these procedures. One such factor is
bone cement: antibiotic or plain. Does the
higher-priced antibiotic bone really prevent
infections after arthroplasty procedures?
Health Technology Trends looks at a synop-
sis of research on evidence and costs from
an ECRI Institute webinar on the topic, held
February 8, 2016.
Arthroplasty Uptick
According to 2010 National Hospital
Discharge Survey Data, 332,000 total hip
replacements (THRs) and 719,000 total knee
replacements (TKRs) are performed annually.
Joint replacement rates are rising: The National
Center for Health Statistics projects 572,000
THRs in 2030 and 3.48 million TKRs for the
same year.
Holding It Together
During THR, the damaged femoral head is
removed and replaced with a metal head on
a metal stem placed into the femoral shaft.
The stem may be press-fit (cementless) or
cemented into the femoral shaft, explained
David Snyder, PhD, senior research analyst for
ECRI Institute’s Health Technology Assessment
Information Service, in a webinar.
Bone cement is also used during TKRs,
during which damaged cartilage and bone are
removed from the distal femur and proximal
tibia and metal and plastic implants are either
press-fit or cemented.
“The bone cement used to attach prosthet-
ics to bone is based on the polymerization of
methyl methacrylate monomers to polymethyl
methacrylate (PMMA),” said Snyder. “PMMA-
based cements are prepared by mixing a
powdered polymer and a liquid monomer.”
Snyder noted that PMMA may cause allergic
reactions in some patients.
A major concern with arthroplasty is infec-
tion. Snyder explained that the presence of
biomaterials in orthopedic surgery procedures
is associated with a higher risk of infections.
Specific physical and chemical properties of
biomaterials, such as bone cement, allow
Bone cement
(continued on page 2)
Palacos®
R and Palacos R+G plain and antibiotic bone cement.
Photo courtesy of Zimmer Biomet.